Carmofur, >= 98%( HPLC ), poudre

Code: c1494-50mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Carmofur has been used as an inhibitor of acid ceramidase to study its effects on glucosylsphingosine (GlcSph) production in human embryonic kidney 293T (HEK293T)...


en savoir plus

Votre prix
$455.30 50MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Carmofur has been used as an inhibitor of acid ceramidase to study its effects on glucosylsphingosine (GlcSph) production in human embryonic kidney 293T (HEK293T) cells. It has also been used as an inhibitor of acid ceramidase to study its effects on acid‐mediated hydrolysis of ceramide which kicks-in consumption and the generation of sphingosine .

Biochem/physiol Actions

Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent.

Carmofur acts as an inhibitor of fatty acid amide hydrolase (FAAH), N-acylethanolamine acid amidase (NAAA) and acid ceramidase (ASAH1). Carmofur has a therapeutic activity against colorectal and cervical cancer. It can inhibit the severe acute respiratory syndrome (SARS)-CoV-2 main protease (Mpro) in vitro.

Packaging

10, 50 mg in glass bottle

assay≥98% (HPLC)
colorwhite to off-white
formpowder
InChI keyAOCCBINRVIKJHY-UHFFFAOYSA-N
InChI1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18)
Quality Level100
SMILES stringCCCCCCNC(=O)N1C=C(F)C(=O)NC1=O
solubilityDMSO: >15 mg/mL
storage temp.2-8°C
Code
Description
Unité de vente
Prix annoncé
Qté
C1494-10MG
Carmofur, >= 98%( HPLC ), poudre

Unité:10MG
Prix annoncé: $113.45
Source:Prix annoncé
AJOUTER
Cas Number61422-45-5
Hazard Class6.1
Un Number2811
Pack Group2
Ce produit répond aux critères suivants: